Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duavee for breast cancer risk reduction pilot
NCT02729701Phase 2Completed
- Sponsor
- University of Kansas Medical Center
- Start
- May 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bazedoxifene in breast cancer, sponsored by University of Kansas Medical Center. Started May 2016; status: completed.
02
Drugs
bazedoxifene
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02729701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02729701.